购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Endogenous Metabolite
    (1)
  • PKC
    (1)
  • Others
    (15)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 5日内发货
    (2)
  • 20日内发货
    (1)
  • 35日内发货
    (2)
筛选
搜索结果
TargetMol产品目录中 "

a-galactosylceramide

"的结果
  • 抑制剂&激动剂
    20
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    1
    TargetMol | Recombinant_Protein
  • 多肽产品
    2
    TargetMol | Peptide_Products
  • 染料试剂
    3
    TargetMol | Dye_Reagents
  • 天然产物
    2
    TargetMol | Natural_Products
  • 分子与细胞研究
    1
    TargetMol | Inhibitors_Agonists
  • α-Galactosylceramide
    KRN7000, α-GalCer
    T14193158021-47-7
    α-Galactosylceramide (KRN7000) 是一种具有抗肿瘤和免疫刺激作用的合成糖脂。它是一种高效的 NKT 细胞激动剂,可与 CD1d 有效结合。它与 CD1d 的复合物可与 NKT 细胞的 T 细胞抗原受体结合。
    • ¥ 1980
    In stock
    规格
    数量
  • C16 Galactosylceramide
    T20325834324-89-5
    C16 Galactosylceramide 是一种鞘脂类化合物,参与脂质代谢和免疫调节等细胞内的生理过程,亦可用于糖尿病研究。
    • 待询
    规格
    数量
  • Psychosine
    鞘氨醇半乳糖苷, Sphingosine galactoside, Galactosylsphingosine (d18:1), Galactosylsphingosine
    T212602238-90-6
    Psychosine (Galactosylsphingosine) 是一种 PKC 抑制剂,是半乳糖脑苷脂酶 (GALC) 酶的底物,是 Krabbe 病的潜在生物标志物。Psychosine 具有很强的细胞毒性,可诱导多种细胞死亡。
    • 待估
    35日内发货
    规格
    数量
  • α-GalCer analog 8
    α-GalCer analog 8,α-Galactosylceramide analog 8
    T35450922727-14-8
    α-Galactosylceramide analog 8 (α-GalCer analog 8) is a triazole derivative of α-galactosylceramide. [1] It increases IL-2 secretion by DN32.D3 NKT hybridoma cells when co-cultured with CD1d-transfected RBL cells pre-loaded with α-GalCer analog 8 at a concentration of 32 ng ml. α-GalCer analog 8 (32 ng ml) induces IL-4 secretion to a greater extent than the synthetic α-GalCer KRN 7000 in mouse splenocytes in vitro and in mouse serum following administration of a 1 µg per animal dose, indicating a Th2 response.
    • ¥ 4230
    35日内发货
    规格
    数量
  • Sulfatides (bovine) (sodium salt)
    T35639
    Sulfatides are endogenous sulfoglycolipids with various biological activities in the central and peripheral nervous systems, pancreas, and immune system. They are produced from the combination of ceramide and UDP-galactose in the endoplasmic reticulum followed by sulfation in the Golgi apparatus. The ceramide portion contains variable fatty acid chain lengths, which are tissue- and pathology-dependent. Sulfatides are primarily found in the myelin sheath of oligodendrocytes and Schwann cells, with smaller chain lengths predominant during development and longer chain lengths predominant in mature cells. They accumulate in the lysosome of patients with metachromatic leukodystrophy, a disorder characterized by arylsulfatase A deficiency. Sulfatides are also located in pancreatic β-cells and inhibit insulin release from isolated rat pancreatic islet cells, suggesting a potential role in diabetes. Sulfatides can induce inflammation in glia in vitro and certain sulfatides, such as C24:1 3'-sulfo-galactosylceramide, can induce an immune response in vitro in mouse splenocytes. Sulfatides (bovine) (sodium salt) is a mixture of isolated bovine sulfatides.
    • 待询
    规格
    数量
  • C8 Galactosylceramide (d18:1/8:0)
    C8 Galactosylceramide (d18:1 8:0)
    T3632341613-16-5
    C8 Galactosylceramide is a synthetic C8 short-chain derivative of known membrane microdomain-forming sphingolipids. It increases the amount delivered and toxicity of doxorubicin in cancerous but not non-cancerous cells when incorporated into the nanoliposomal membrane of nanoliposomal-doxorubicin. C8 Galactosylceramide induces proliferation and cytokine production by splenocytes in vitro at concentrations ranging from 100-1,000 ng ml but has no effect on natural killer T cell production in vivo. It also activates NF-κB production in C6 glioma cells when used at a concentration of 10 μM.
    • ¥ 6758
    待询
    规格
    数量
  • C12 Galactosylceramide (d18:1/12:0)
    T3685841613-14-3
    C12 Galactosylceramide is a bioactive sphingolipid. It inhibits IL-4 production by 53.84% in EL4 T cells when used at a concentration of 10 μM. C12 Galactosylceramide reduces the growth of human papillomavirus type 16-associated tumors in mice and reduces tumor recurrence following surgical removal or chemotherapy. It also reduces natural killer T cell activity, delays the onset of proteinuria, and improves survival in a mouse model of systemic lupus.
    • ¥ 3580
    5日内发货
    规格
    数量
  • C2 Adamantanyl Galactosylceramide (d18:1/2:0)
    T37440574738-16-2
    C2 Adamantanyl Galactosylceramide (d18:1 2:0) (AdaGalCer) is a bioactive sphingolipid. It reduces globotriaosylceramide 3 synthesis from exogenous lactosylceramide in microsomes. AdaGalCer stimulates recombinant glucocerebrosidase activity in a pH-dependent manner. It activates glucocerebrosidase to decrease glucosylceramide accumulation in fibroblasts and lymphoblasts isolated from patients with Gaucher and Fabry disease, respectively.
    • ¥ 6758
    待询
    规格
    数量
  • C16 Galactosylceramide (d18:1/16:0)
    C16 Galactosylceramide (d18:1 16:0)
    T37872
    C16 Galactosylceramide is a glycosphingolipid that contains a galactose moiety attached to a ceramide acylated with palmitic acid .
    • ¥ 770
    待询
    规格
    数量
  • KBC-007
    T380081037297-61-2
    KBC-007 is a synthetic branched chain-containing analog of α-galactosylceramide (α-GalCer). It induces IL-4 and IFN-γ secretion by mouse splenocytes when used at a concentration of 0.5 ng/ml and IL-2 secretion by DN32.D3 NKT hybridoma cells co-cultured with CD1d-transfected RBL cells pre-loaded with KBC-007 at a concentration of 8 ng/ml. KBC-007 (1 μg per animal) increases levels of IL-4, but not IFN-γ, to a similar degree as α-GalCer in mouse serum. KBC-007 (0.5 μg per animal) increases the survival rate of mice immunized with the inactivated influenza A virus A/PR/8/34 in a model of influenza infection.
    • ¥ 9784
    待询
    规格
    数量
  • C16 3'-sulfo Galactosylceramide (d18:1/16:0)
    C16 3'-sulfo Galactosylceramide (d18:1 16:0)
    T3817989771-78-8
    C16 3'-sulfo Galactosylceramide (d18:1 16:0)是硫酸盐类糖脂的一种。C16 3'-sulfo Galactosylceramide (d18:1 16:0)是在猪脑和血浆中发现的一种比较丰富的硫化物,在小鼠的整个发育过程中会有所减少。C16 3'-sulfo Galactosylceramide (d18:1 16:0)在体外可抑制视网膜神经节细胞生长。C16 3'-sulfo Galactosylceramide (d18:1 16:0)已被用作量化大鼠小脑和多发性硬化症患者分离的白质中的硫化物的参照物。
    • ¥ 11680
    待询
    规格
    数量
  • C18 3'-sulfo Galactosylceramide (d18:1/18:0)
    C18 3'-sulfo Galactosylceramide (d18:1 18:0)
    T38183244215-65-4
    C18 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. Levels of short-chain sulfatides, including C18 3'-sulfo galactosylceramide, decrease with age in mice and humans. It is increased in brain from mice with an arylsulfatase A deficiency (ASA-KO), particularly in lipid raft fractions. Plasma levels of C18 3'-sulfo galactosylceramide positively correlate with disability progression in patients with relapsing-remitting multiple sclerosis using the Expanded Disability Status Scale. It is also increased in plasma from patients with metachromatic leukodystrophy (MLD).
    • ¥ 12150
    待询
    规格
    数量
  • C18:1 3'-sulfo Galactosylceramide (d18:1/18:1(9Z))
    C18:1 3'-sulfo Galactosylceramide (d18:1 18:1(9Z))
    T381841292769-40-4
    C18:1 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. It has been found in mouse brain. It has been used as a standard for the quantification of C18:1 3'-sulfo galactosylceramide in dried blood spots from patients with metachromatic leukodystrophy (MLD) by UPLC-MS.
    • ¥ 12150
    待询
    规格
    数量
  • C2 3'-sulfo Galactosylceramide (d18:1/2:0)
    C2 3'-sulfo Galactosylceramide (d18:1 2:0)
    T38185252846-08-5
    C2 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. It has been used as an internal standard in the quantification of lysosulfatides in mouse brain tissue and plasma.
    • ¥ 12150
    待询
    规格
    数量
  • C22 Galactosylceramide (d18:1/22:0)
    T3828174645-25-3
    C22 Galactosylceramide is a sphingolipid that has been found in the central nervous system.1,2C22 Galactosylceramide levels are increased in the spinal cord, but not the brain or liver, of mice fed a methionine-restricted diet.1C22 Galactosylceramide has been found in postmortem hippocampus from patients with Alzheimer's disease.2[Matreya, LLC.]
    • ¥ 9280
    待询
    规格
    数量
  • Tetracosanoyl-sulfatide
    C24 3'-sulfo Galactosylceramide (d18:1 24:0)
    T38283151122-71-3
    Tetracosanoyl-sulfatide is an endogenous sulfated glycolipid, which are also known as sulfatides . Tetracosanoyl-sulfatide is the major sulfatide in mature myelin in the central and peripheral nervous systems. Levels of Tetracosanoyl-sulfatide are elevated in plasma derived from patients with metachromatic leukodystrophy, a disorder characterized by arylsulfatase A deficiency, leading to sulfatide accumulation. Unlike C24:1 3'-sulfo galactosylceramide, it does not induce an immune response in mouse splenocytes in vitro.
    • ¥ 12150
    待询
    规格
    数量
  • αGalCer-RBD
    T74326
    αGalCer-RBD 是一种佐剂脂蛋白结合物。αGalCer-RBD 可诱导对 SARS-CoV-2及其变异毒株的有效免疫。αGalCer-RBD 结合物诱导 RBD 特异性、产生细胞因子的 T 细胞发育。αGalCer-RBD 有望成为一种有效的 COVID-19 疫苗候选化合物。α-Galactosylceramide (αGalCer) 是一种有效的不变自然杀伤 T 细胞 (iNKT) 激动剂。
    • 待询
    规格
    数量
  • Retrocyclin-1
    T81295724760-19-4
    Retrocyclin-1是一种θ防御素,具有识别并结合含碳水化合物表面分子的能力,能够保护细胞抵御HIV-1感染。该化合物对胎球蛋白、gp120(Kd=35.4 nM)、CD4(Kd=31 nM)以及半乳糖神经酰胺(Kd=24.1 nM)展现出高度亲和性。
    • 待询
    规格
    数量
  • C12 3'-sulfo Galactosylceramide (d18:1/12:0)
    3'-sulfo Galactosylceramide (d18:1 12:0), ​N-Dodecanoyl Sulfatide, (3'-sulfo)Galβ-Cer(d18:1 12:0), C12 Sulfatide
    T85185852100-88-0
    C12 3'-sulfo Galactosylceramide (d18:1 12:0) 是一种脂质分子,可用于生命科学相关研究,其 CAS 号为 852100-88-0。
    • 待询
    8-10周
    规格
    数量
  • Galactosylceramidase
    TXB-00455
    Galactosylceramidase 参与半乳糖神经酰胺在溶酶体中的代谢,并可用于克拉伯病的研究。
    • 待询
    5日内发货
    规格
    数量
没有更多数据了